What is the appropriate weight‑based dose for a 47‑kg patient?

Weight-Based Dosing for a 47 kg Patient

For a 47 kg patient, dosing should follow adult weight-based guidelines when the patient weighs more than 40 kg, as established by major tuberculosis treatment guidelines 1, 2.

Key Dosing Principle

The critical threshold is 40 kg body weight. According to ATS/CDC/IDSA tuberculosis treatment guidelines, children weighing more than 40 kg should be dosed as adults 1, 2. This principle applies broadly across weight-based medication dosing, where 47 kg places the patient firmly in the adult dosing category.

Specific Considerations by Drug Class

For Tuberculosis Medications (if applicable):

• Isoniazid: 5 mg/kg daily (maximum 300 mg) = 235 mg daily for this patient 2
• Rifampin: 10 mg/kg daily (maximum 600 mg) = 470 mg daily for this patient 2
• Pyrazinamide: 15-30 mg/kg daily = 705-1410 mg daily for this patient 2
• Ethambutol: 15-20 mg/kg daily = 705-940 mg daily for this patient 2

General Weight-Based Dosing Principles:

Use total body weight (TBW) for most medications unless the patient has obesity (BMI ≥30 kg/m²), in which case adjusted body weight may be more appropriate for certain drug classes 3, 4.

For a 47 kg patient who is likely not obese:

• Calculate doses using actual body weight
• Do not cap doses arbitrarily - full weight-based dosing is essential for efficacy 4
• Monitor for therapeutic response and toxicity as with any patient

Critical Caveats:

1. Underweight patients (<50 kg): For IV paracetamol specifically, patients <50 kg require dose adjustment to 15 mg/kg every 4-6 hours (maximum 60 mg/kg daily), NOT the standard 1 gram QDS 5

2. Anticoagulation: For enoxaparin and other low-molecular-weight heparins, weight-based dosing using actual body weight is safe and appropriate at 47 kg 6

3. Chemotherapy: Full weight-based dosing should be used regardless of body size to avoid suboptimal treatment 4

Documentation Requirements

Always document the patient's weight in kilograms on the medication chart to ensure proper dose calculations and prevent medication errors 5, 7. This is particularly critical for:

• Weight-based medications requiring precise dosing
• Medications with narrow therapeutic windows
• Pediatric-to-adult transition patients

The 47 kg weight should trigger adult dosing protocols while maintaining vigilance for medications that require specific adjustments in patients weighing less than 50 kg.